Multiple antibiotics exert delayed effects against the Plasmodium falciparum anicoplast

被引:235
作者
Dahl, Erica L.
Rosenthal, Philip J.
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.1128/AAC.00527-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Several classes of antibiotics exert antimalarial activity. The mechanisms of action of antibiotics against malaria parasites have been unclear, and prior studies have led to conflicting results, in part because they studied antibiotics at suprapharmacological concentrations. We examined the antimalarial effects of azithromycin, ciprofloxacin, clindamycin, doxycycline, and rifampin against chloroquine-resistant (W2) and chloroquine-sensitive (3D7) Plasmodium falciparum strains. At clinically relevant concentrations, rifampin killed parasites quickly, preventing them from initiating cell division. In contrast, pharmacological concentrations of azithromycin, ciproffoxacin, clindamycin, and doxycycline were relatively inactive against parasites initially but exerted a delayed death effect, in which the progeny of treated parasites failed to complete erythrocytic development. The drugs that caused delayed death did not alter the distribution of apicoplasts into developing progeny. However, the apicoplasts inherited by the progeny of treated parasites were abnormal. The loss of apicoplast function became apparent as the progeny of antibiotic-treated parasites initiated cell division, with the failure of schizonts to fully mature or for erythrocyte rupture to take place. These findings explain the slow antimalarial action of multiple antibiotics.
引用
收藏
页码:3485 / 3490
页数:6
相关论文
共 49 条
[1]   Drug therapy: Effectiveness of antimalarial drugs [J].
Baird, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1565-1577
[2]   Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil; a study conducted in 1996 in the French Army [J].
Baudon, D ;
Martet, G ;
Pascal, B ;
Bernard, J ;
Keundjian, A ;
Laroche, R .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (03) :302-303
[3]   INHIBITION OF CYTOPLASMIC AND ORGANELLAR PROTEIN-SYNTHESIS IN TOXOPLASMA-GONDII - IMPLICATIONS FOR THE TARGET OF MACROLIDE ANTIBIOTICS [J].
BECKERS, CJM ;
ROOS, DS ;
DONALD, RGK ;
LUFT, BJ ;
SCHWAB, JC ;
CAO, Y ;
JOINER, KA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :367-376
[4]   The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing [J].
Begg, EJ ;
Robson, RA ;
Saunders, DA ;
Graham, GG ;
Buttimore, RC ;
Neill, AM ;
Town, GI .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (01) :32-38
[5]   Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria [J].
Borrmann, S ;
Issifou, S ;
Esser, G ;
Adegnika, AA ;
Ramharter, M ;
Matsiegui, PB ;
Oyakhirome, S ;
Mawili-Mboumba, DP ;
Missinou, MA ;
Kun, JFJ ;
Jomaa, H ;
Kremsner, PG .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1534-1540
[6]  
Breman JG, 2001, AM J TROP MED HYG, V64, P1
[7]   An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii [J].
Camps, M ;
Arrizabalaga, G ;
Boothroyd, J .
MOLECULAR MICROBIOLOGY, 2002, 43 (05) :1309-1318
[8]   The apicoplast of Plasmodium falciparum is translationally active [J].
Chaubey, S ;
Kumar, A ;
Singh, D ;
Habib, S .
MOLECULAR MICROBIOLOGY, 2005, 56 (01) :81-89
[9]  
Clough B, 2001, INFEC DIS S, P265
[10]   Thiostrepton binds to malarial plastid rRNA [J].
Clough, B ;
Strath, M ;
Preiser, P ;
Denny, P ;
Wilson, I .
FEBS LETTERS, 1997, 406 (1-2) :123-125